Dyne Therapeutics, Inc.

DYN·NasdaqGS·Healthcare
Compare
15.96−0.68 (−4.09%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours15.960.00 (0.00%)Oct 12, 4:26 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close16.64
Open16.54
Day range15.7316.76
52-week range13.7327.31
Off day high−4.77%
Off 52-week high−41.55%
Volume2.92M
Avg. volume (3M)2.88M
Market cap2.98B
EPS (TTM)-3.30
Forward P/E-4.79
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.12
Shares outstanding186.75M
Short interest17.79% of float
Earnings dateNov 5, 2026 (est.)
Analyst target35.73
Profit margin0.00%

Against its peers

Compare in full ›
DYN DSGN EWTX SRPT SLDB DNTH
Market cap 2.98B 682.77M 4.18B 1.84B 719.48M 4.56B
P/E (TTM) — — — — — —
Forward P/E -4.8 -6.7 -21.2 7.3 -3.9 -17.7
Price/book 3.8 3.4 9.2 1.2 1.9 3.8
Dividend yield — — — — — —
1-year change +18.60% +79.51% +165.53% −18.72% +14.31% +139.31%
Today −4.09% −6.35% −1.56% −2.30% −2.33% −0.97%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Dyne Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Design Therapeutics, Inc.DSGN · Biotechnology 682.77M 10.91 −6.35%
Edgewise Therapeutics, Inc.EWTX · Biotechnology 4.18B 38.45 −1.56%
Sarepta Therapeutics, Inc.SRPT · Biotechnology 1.84B 17.44 −2.30%
Solid Biosciences Inc.SLDB · Biotechnology 719.48M 6.71 −2.33%
Dianthus Therapeutics, Inc.DNTH · Biotechnology 4.56B 81.57 −0.97%
PTC Therapeutics, Inc.PTCT · Biotechnology 5.25B 62.92 −2.75%
Denali Therapeutics Inc.DNLI · Biotechnology 3.03B 18.95 −2.57%
Definium Therapeutics, Inc.DFTX · Biotechnology 4.73B 35.20 −4.61%

Also based in Waltham, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Thermo Fisher Scientific Inc.TMO · Waltham, MAOdds 244.86B 662.24 +0.64%
Veralto CorporationVLTO · Waltham, MA 23.94B 98.20 +1.31%
Revvity, Inc.RVTY · Waltham, MA 17.36B 155.61 +0.93%
Repligen CorporationRGEN · Waltham, MA 10.95B 172.51 −0.79%
Spyre Therapeutics, Inc.SYRE · Waltham, MA 8.03B 85.90 +0.25%
Pegasystems Inc.PEGA · Waltham, MA 5.74B 34.91 −2.08%
Cogent Biosciences, Inc.COGT · Waltham, MA 5.17B 29.78 −3.94%
Crane NXT, Co.CXT · Waltham, MA 2.94B 51.11 +1.31%

The stocks whose daily moves over the past year went most closely with Dyne Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Solid Biosciences Inc.SLDB · Correlation 0.47 719.48M 6.71 −2.33%
Arcus Biosciences, Inc.RCUS · Correlation 0.47 3.06B 24.34 −0.29%
IDEAYA Biosciences, Inc.IDYA · Correlation 0.46 3.48B 36.06 −0.14%
Sarepta Therapeutics, Inc.SRPT · Correlation 0.44 1.84B 17.44 −2.30%
Denali Therapeutics Inc.DNLI · Correlation 0.43 3.03B 18.95 −2.57%
PTC Therapeutics, Inc.PTCT · Correlation 0.41 5.25B 62.92 −2.75%
Dianthus Therapeutics, Inc.DNTH · Correlation 0.39 4.56B 81.57 −0.97%
Design Therapeutics, Inc.DSGN · Correlation 0.38 682.77M 10.91 −6.35%

What visitors to Dyne Therapeutics's page also look at.

Company Mkt cap Price Today
Empire Petroleum CorporationEP 135.21M 3.2500 +3.17%
The AES CorporationAES 10.69B 14.98 +0.27%
Mirion Technologies, Inc.MIR 4.05B 16.25 −2.23%
CMS Energy CorporationCMS 20.65B 65.86 +0.56%
Williams Companies, Inc. (The)WMB 90.72B 74.17 +2.06%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All DYN news ›
Pluang·Positive

Dyne Therapeutics rated 'risky Buy' after 30% d...

Dyne Therapeutics is considered a 'risky Buy' following a stock drop of over 30%, seen as a contrarian opportunity amid biotech sector volatility. The company's promising Phase 1/2 data for Z-Rostudirsen in Duchenne Muscular Dystrophy…

Pluang·Positive

Dynex Capital issues 9.375% preferred stock wit...

Dynex Capital has launched a 9.375% Series D Cumulative Preferred Stock (DXPRD) trading OTC with a yield near 9.5%, offering a higher current yield than peers like AGNCZ and NLY-J. The stock benefits from Dynex's agency-backed portfolio,…

From articles in the 4Search news index.

In the news

6mentions in 30 days
2with it in the headline
Positivesentiment

Mentioned with

Dyne Therapeutics, Inc.6Jefferies6Morgan Stanley6Evercore Isi5Lifesci Capital4Citigroup2Dxs International Plc2Dynacert Inc.2

People in the coverage

Duchenne6Raymond James6Bitcoin4Bitmine3Dynatrace3Solana3

Themes

Announces4Offering3Canada2Canadian Finance2Dya.to2Equities2ETFS2Financial Calculators2

Most coverage from

  1. pluang.com2
  2. tradingview.com2
  3. kalkinemedia.com1
  4. themarketsdaily.com1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.